February 22, 2013

European Medicines Agency Recommends Approval of Hexyon/Hexacima 6-in-1 Pediatric Vaccine

Hexyon/Hexacima will be the only fully liquid, ready-to-use, 6-in-1 pediatric vaccine in Europe

 

European Medicines Agency Recommends Approval of Hexyon/Hexacima 6-in-1 Pediatric Vaccine
Hexyon/Hexacima will be the only fully liquid, ready-to-use, 6-in-1 pediatric vaccine in Europe

Lyon, France – February 22, 2013 – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended market approval for Sanofi Pasteur’s 6-in-1 pediatric vaccine HexyonTM/HexacimaTM (DTaP-IPV-Hib-HepB vaccine).